SEC Filing Summary: Concord Acquisition Corp III (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Concord Acquisition Corp III (the "Company") on April 6, 2023. The Company is a Special Purpose Acquisition Company (SPAC) incorporated in Delaware and listed on the New York Stock Exchange under the symbols CNDB.U, CNDB, and CNDB.WS. The report details a material definitive agreement entered into to support an upcoming stockholder vote.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. As a SPAC in the pre-business combination phase, the Company's primary financial focus is the preservation of funds in its trust account. The filing notes that the new agreements are expected to increase the amount of funds remaining in the trust account following the upcoming stockholder meeting, though specific dollar amounts are not disclosed in this text.
Material Changes and Agreements
On April 6, 2023, the Company and its sponsor, Concord Sponsor Group III LLC, entered into "Non-Redemption Agreements" with third-party investors. Key terms include:
- Purpose: To secure agreements from investors not to redeem their public shares at the special meeting scheduled for May 4, 2023.
- Consideration: Investors receive an allocation of 100,000 shares of Class B common stock ("Founder Shares") held by the Sponsor in exchange for agreeing to hold their public shares.
- Extension Proposal: The agreements support a proposal to extend the deadline to consummate an initial business combination from May 8, 2023, to November 8, 2023.
- Termination: Agreements terminate if the extension is not approved, obligations are fulfilled, the Company liquidates, or if the investor exercises redemption rights.
Outlook, Risks, and Management Commentary
Management states that while these agreements are not expected to increase the likelihood of stockholder approval for the extension, they are expected to preserve more capital in the trust account. The filing includes standard forward-looking statement disclaimers regarding risks such as:
- Failure to obtain stockholder approval for the extension.
- Inability to complete a business combination within the required timeframe.
- Uncertainty regarding the final amount of funds available in the trust account post-extension.
Investors are directed to the Proxy Statement filed on April 6, 2023, for detailed risk factors and information regarding the solicitation of proxies.
Investor Verification Checklist
- Verify the total number of shares covered by the Non-Redemption Agreements and the total number of Founder Shares allocated.
- Review the Proxy Statement (filed April 6, 2023) for the exact amount of cash currently in the trust account and the projected amount post-extension.
- Confirm the specific terms of the extension proposal, including any additional contributions required from the Sponsor to maintain the trust balance.
- Check for any additional Non-Redemption Agreements entered into after the date of this filing.